| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 708 | 2018 |
| Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised … M Azizi, M Sapoval, P Gosse, M Monge, G Bobrie, P Delsart, M Midulla, ... The Lancet 385 (9981), 1957-1965, 2015 | 530 | 2015 |
| Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study P Gosse, DJ Sheridan, F Zannad, O Dubourg, P Guéret, Y Karpov, ... Journal of hypertension 18 (10), 1465-1475, 2000 | 527 | 2000 |
| Nocturnal blood pressure fall on ambulatory monitoring in a large international database JA Staessen, L Bieniaszewski, E O'Brien, P Gosse, H Hayashi, Y Imai, ... Hypertension 29 (1), 30-39, 1997 | 477 | 1997 |
| Blood pressure surge on rising P Gosse, R Lasserre, C Minifié, P Lemetayer, J Clementy Journal of hypertension 22 (6), 1113-1118, 2004 | 355 | 2004 |
| Ambulatory blood pressure monitoring versus self-measurement of blood pressure at home: correlation with target organ damage V Gaborieau, N Delarche, P Gosse Journal of hypertension 26 (10), 1919-1927, 2008 | 288 | 2008 |
| ESC Council on hypertension position document on the management of hypertensive emergencies BJH van den Born, GYH Lip, J Brguljan-Hitij, A Cremer, J Segura, ... European Heart Journal–Cardiovascular Pharmacotherapy 5 (1), 37-46, 2019 | 274 | 2019 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 261 | 2021 |
| Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study B Dahlöf, P Gosse, P Guéret, O Dubourg, G De Simone, R Schmieder, ... Journal of hypertension 23 (11), 2063-2070, 2005 | 244 | 2005 |
| Ambulatory blood pressure in normotensive and hypertensive subjects: results from an international database JA Staessen, ET O'Brien, AK Amery, N Atkins, P Baumgart, P De Cort, ... Journal of hypertension 12, S13-S22, 1994 | 236 | 1994 |
| Effects of perioperative α1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma P Tauzin‐Fin, M Sesay, P Gosse, P Ballanger British Journal of Anaesthesia 92 (4), 512-517, 2004 | 210 | 2004 |
| Left ventricular hypertrophy as a predictor of cardiovascular risk P Gosse Journal of hypertension 23, S27-S33, 2005 | 187 | 2005 |
| 'White coat'hypertension. No harm for the heart. P Gosse, H Promax, P Durandet, J Clementy Hypertension 22 (5), 766-770, 1993 | 185 | 1993 |
| Mechanical cardiac valve thrombosis. Is fibrinolysis justified? R Roudaut, T Labbe, MF Lorient-Roudaut, P Gosse, E Baudet, F Fontan, ... Circulation 86 (5 Suppl), II8-15, 1992 | 177 | 1992 |
| Adherence to antihypertensive treatment and the blood pressure–lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial M Azizi, H Pereira, I Hamdidouche, P Gosse, M Monge, G Bobrie, ... Circulation 134 (12), 847-857, 2016 | 163 | 2016 |
| Renal Denervation for Hypertension (DENERHTN) investigators. Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant … M Azizi, M Sapoval, P Gosse, M Monge, G Bobrie, P Delsart, M Midulla, ... Lancet 385 (9981), 1957-1965, 2015 | 155 | 2015 |
| High prevalence of multiple arterial bed lesions in patients with fibromuscular dysplasia: the ARCADIA Registry (Assessment of Renal and Cervical Artery Dysplasia) PF Plouin, JP Baguet, F Thony, O Ormezzano, A Azarine, F Silhol, ... Hypertension 70 (3), 652-658, 2017 | 149 | 2017 |
| Six-month results of treatment-blinded medication titration for hypertension control after randomization to endovascular ultrasound renal denervation or a sham procedure in the … M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, MD Lobo, ... Circulation 139 (22), 2542-2553, 2019 | 147 | 2019 |
| Regression of left ventricular hypertrophy as a surrogate end-point for morbid events in hypertension treatment trials RB Devereux, E Agabiti-Rosei, B Dahlöf, P Gosse, RT Hahn, PM Okin, ... Journal of Hypertension 14, S95-S102, 1996 | 139 | 1996 |
| From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency A Cremer, F Amraoui, GYH Lip, E Morales, S Rubin, J Segura, ... Journal of human hypertension 30 (8), 463-466, 2016 | 130 | 2016 |
